Status:
COMPLETED
The Effects of Cannabidiol and ∆-9-THC in Humans
Lead Sponsor:
Yale University
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
EARLY_PHASE1
Brief Summary
Cannabis is the most commonly used illicit substance in the US and herbal cannabis consists of a number of cannabinoids including Δ-9 THC and CBD. This study will characterize the interactive effects ...
Eligibility Criteria
Inclusion
- Exposed to Cannabis at least once in lifetime
Exclusion
- Cannabis Naive
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2014
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01180374
Start Date
February 1 2010
End Date
October 6 2014
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516